Literature DB >> 9704637

Interleukin-4 suppression of interleukin-1-induced transcription of collagenase (MMP-1) and stromelysin 1 (MMP-3) in human synovial fibroblasts.

R C Borghaei1, P L Rawlings, E Mochan.   

Abstract

OBJECTIVE: To determine the effects of interleukin-4 (IL-4) on IL-1 induction of collagenase (matrix metalloproteinase 1 [MMP-1]) and stromelysin-1 (MMP-3) in human synovial fibroblasts.
METHODS: Northern blot analysis was performed to determine the effects of IL-4 on IL-1 induction of MMP messenger RNA (mRNA). MMP protein levels were determined by enzyme-linked immunosorbent assay, and prostaglandin E2 (PGE2) levels were measured by enzyme immunoassay. Run-on transcription assays and transient transfection experiments were performed to determine whether the effects of IL-4 occur at the level of transcription. Activator protein 1 (AP-1) binding was assessed by electrophoretic mobility shift assay.
RESULTS: Northern blot analysis revealed that coincubation of synovial fibroblasts with IL-1 and IL-4 resulted in a significant decrease in both collagenase and stromelysin mRNA levels compared with IL-1 alone, with a concomitant decrease in MMP protein levels. This inhibition is dose dependent, with an IC50 (50% inhibition concentration) for both MMPs of approximately 0.3 ng of IL-4 per ml, and is at least somewhat selective, since IL-1 induction of c-fos mRNA is not affected. Nuclear run-on experiments and transient transfection studies demonstrated that the suppression of IL-1-induced collagenase and stromelysin expression by IL-4 occurs at least in part at the transcriptional level, and that binding of transcription factor AP-1 is not affected. Although IL-1-induced levels of PGE2 are reduced by IL-4, exogenous addition of PGE2 does not abrogate the inhibitory effects of IL-4 on MMP expression.
CONCLUSION: IL-4 inhibits IL-1 induction of both collagenase and stromelysin, as well as PGE2 production, in human synovial fibroblasts. The inhibition occurs at least in part at the level of transcription, does not affect binding of transcription factor AP-1, and appears to involve a mechanism that is independent of the ability of IL-4 to inhibit production of PGE2.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9704637      PMCID: PMC1602062          DOI: 10.1002/1529-0131(199808)41:8<1398::AID-ART8>3.0.CO;2-B

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  45 in total

1.  Interleukin-4 inhibits prostaglandin E2 production by freshly prepared adherent rheumatoid synovial cells via inhibition of biosynthesis and gene expression of cyclo-oxygenase II but not of cyclo-oxygenase I.

Authors:  E Sugiyama; H Taki; A Kuroda; T Mino; N Yamashita; M Kobayashi
Journal:  Ann Rheum Dis       Date:  1996-06       Impact factor: 19.103

2.  Molecular characterization of a novel transcription factor that controls stromelysin expression.

Authors:  L Sanz; J Moscat; M T Diaz-Meco
Journal:  Mol Cell Biol       Date:  1995-06       Impact factor: 4.272

3.  Effects of IL-10 and IL-4 on LPS-induced transcription factors (AP-1, NF-IL6 and NF-kappa B) which are involved in IL-6 regulation.

Authors:  W H Dokter; S B Koopmans; E Vellenga
Journal:  Leukemia       Date:  1996-08       Impact factor: 11.528

4.  The role of IL-4 and IL-6 in IL-1-dependent cartilage matrix degradation.

Authors:  M Shingu; S Miyauchi; Y Nagai; C Yasutake; K Horie
Journal:  Br J Rheumatol       Date:  1995-02

5.  Coordinate regulation of matrix metalloproteases and tissue inhibitor of metalloproteinase expression in human synovial fibroblasts.

Authors:  J A DiBattista; J P Pelletier; M Zafarullah; N Fujimoto; K Obata; J Martel-Pelletier
Journal:  J Rheumatol Suppl       Date:  1995-02

6.  Promoter elements in the transcriptional activation of the human stromelysin-1 gene by the inflammatory cytokine, interleukin 1.

Authors:  S Quinones; G Buttice; M Kurkinen
Journal:  Biochem J       Date:  1994-09-01       Impact factor: 3.857

7.  Interleukin-4 (IL-4) induces down-modulation and shedding of the p55 tumour necrosis factor receptor and inhibits TNF alpha's effect on rheumatoid synovial fibroblasts.

Authors:  D J Taylor
Journal:  Rheumatol Int       Date:  1994       Impact factor: 2.631

8.  Balance of IL-1 receptor antagonist/IL-1 beta in rheumatoid synovium and its regulation by IL-4 and IL-10.

Authors:  P Chomarat; E Vannier; J Dechanet; M C Rissoan; J Banchereau; C A Dinarello; P Miossec
Journal:  J Immunol       Date:  1995-02-01       Impact factor: 5.422

9.  Prostaglandins E2 and E1 inhibit cytokine-induced metalloprotease expression in human synovial fibroblasts. Mediation by cyclic-AMP signalling pathway.

Authors:  J A DiBattista; J Martel-Pelletier; N Fujimoto; K Obata; M Zafarullah; J P Pelletier
Journal:  Lab Invest       Date:  1994-08       Impact factor: 5.662

10.  Inhibition by Interleukin-4 of stromelysin expression in human skin fibroblasts: role of PKC.

Authors:  C Prontera; G Crescenzi; D Rotilio
Journal:  Exp Cell Res       Date:  1996-04-10       Impact factor: 3.905

View more
  18 in total

1.  Protective effects of interleukin-4 on tissue destruction and morphological changes of bovine nasal chondrocytes in vitro.

Authors:  Maryam Yadegari; Mahmoud Orazizadeh; Mahmoud Hashemitabar; Ali Khodadadi
Journal:  Iran Biomed J       Date:  2013

2.  Identification of a cytokine-induced repressor of interleukin-1 stimulated expression of stromelysin 1 (MMP-3).

Authors:  R C Borghaei; C Sullivan; E Mochan
Journal:  J Biol Chem       Date:  1999-01-22       Impact factor: 5.157

3.  Interleukin 13 blocks the release of collagen from bovine nasal cartilage treated with proinflammatory cytokines.

Authors:  C S Cleaver; A D Rowan; T E Cawston
Journal:  Ann Rheum Dis       Date:  2001-02       Impact factor: 19.103

4.  Combination effects of prednisolone and interleukin-4 protect bovine nasal cartilage explants from interleukin-1α induced degradation.

Authors:  Maryam Yadegari; Mahmoud Orazizadeh; Mahmoud Hashemitabar; Ali Khodadadi
Journal:  Iran Biomed J       Date:  2011

5.  T(H)2 predominant immune responses prevail in human abdominal aortic aneurysm.

Authors:  Uwe Schönbeck; Galina K Sukhova; Norbert Gerdes; Peter Libby
Journal:  Am J Pathol       Date:  2002-08       Impact factor: 4.307

6.  Anti-CD4 monoclonal antibody treatment in acute and early chronic antigen induced arthritis: influence on macrophage activation.

Authors:  K Nissler; D Pohlers; M Hückel; J Simon; R Bräuer; R W Kinne
Journal:  Ann Rheum Dis       Date:  2004-11       Impact factor: 19.103

7.  IL-4 inhibition of IL-1 induced Matrix metalloproteinase-3 (MMP-3) expression in human fibroblasts involves decreased AP-1 activation via negative crosstalk involving of Jun N-terminal kinase (JNK).

Authors:  Mariah Chambers; Garrett Kirkpatrick; Michel Evans; Grzegorz Gorski; Sara Foster; Ruth C Borghaei
Journal:  Exp Cell Res       Date:  2013-04-19       Impact factor: 3.905

8.  Distinct in vivo roles of CD80 and CD86 in the effector T-cell responses inducing antigen-induced arthritis.

Authors:  Dragana Odobasic; Michelle T Leech; Jin R Xue; Stephen R Holdsworth
Journal:  Immunology       Date:  2008-01-24       Impact factor: 7.397

9.  Defining therapeutic targets by using adenovirus: blocking NF-kappaB inhibits both inflammatory and destructive mechanisms in rheumatoid synovium but spares anti-inflammatory mediators.

Authors:  J Bondeson; B Foxwell; F Brennan; M Feldmann
Journal:  Proc Natl Acad Sci U S A       Date:  1999-05-11       Impact factor: 11.205

10.  Prostaglandin A2 enhances cellular insulin sensitivity via a mechanism that involves the orphan nuclear receptor NR4A3.

Authors:  X Zhu; R G Walton; L Tian; N Luo; S-R Ho; Y Fu; W T Garvey
Journal:  Horm Metab Res       Date:  2012-10-26       Impact factor: 2.936

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.